Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1611-2023Class II

Teleflex (manufacturer: Vascular SOLUTIONS) D-Stat Flowable Hemostat, REF 4000; for sealing residual oozing...

Teleflex Medical / initiated 2023-04-12 / Open, Classified / root cause: sterility

TELEFLEX LLC began a recall of Teleflex (manufacturer: Vascular SOLUTIONS) D-Stat Flowable Hemostat, REF 4000; for sealing residual oozing of tissue tracts of femoral access sites that have... on . FDA classified it as Class II and gives the reason as "The product contains an expired diluent vial. If the impacted product is used, the sterility of the diluent component cannot be assured as it has passed beyond the studied shelf life of the product". As of , the recall status on record is Open, Classified, and MDM tags the root cause as sterility.

Recall record

Recall number
Z-1611-2023
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Teleflex Medical
Product
Teleflex (manufacturer: Vascular SOLUTIONS) D-Stat Flowable Hemostat, REF 4000; for sealing residual oozing of tissue tracts of femoral access sites that have been previously closed by suture/collagen-based hemostatic devices.
Product code
MGB Device, Hemostasis, Vascular
Reason for recall
The product contains an expired diluent vial. If the impacted product is used, the sterility of the diluent component cannot be assured as it has passed beyond the studied shelf life of the product.
Root cause tag
sterility
FDA root cause
Under Investigation by firm
Action
Teleflex issued an URGENT - MEDICAL DEVICE RECALL notice to its consignees on 04/12/2023 via FedEx 2nd day. The notice explained the issue and the hazard and requested the following actions be taken: Medical Facilities - immediately check your inventory for product within the scope of this recall. Users should cease use and distribution of affected product and immediately quarantine the affected product. If impacted product is on hand, mark the applicable checkbox on the Acknowledgement Form and fax it to 1-855-419-8507, including Attn: Customer Service or using the email address [email protected]. A customer service representative will contact you with a Return Goods Authorization (RGA) Number and will provide instructions for the return of products to Teleflex Medical. Distributors were directed to immediately check your inventory for product within the scope of this recall. Users should cease use and distribution of affected product and immediately quarantine the affected product. They were further directed to notify their customers, collect the response forms, and upon completion of the action forward the completed Acknowledgement Form to [email protected].
Quantity in commerce
1140 units
Distribution
US Nationwide
Product codes and lots
UDI/DI M20640000, Lot Numbers: 717535, exp. 04/27/2023; 717413, exp. 04/25/2023

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1611-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1611-2023Class IIOngoingVoluntary: Firm initiated